We are live on ! Find out more
LP

Lexington Partners Portfolio holdings

AUM $134M
1-Year Est. Return 1.93%
This Fund
S&P 500
This Quarter Est. Return
-5.81%
1 Year Est. Return
-1.93%
3 Year Est. Return
+1.27%
5 Year Est. Return
-12.6%
10 Year Est. Return
–
AUM
$183M
AUM Growth
-$10.8M
Cap. Flow
+$3.45M
Cap. Flow %
1.89%
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
–
Reduced
–
Closed
1

Top Buys

Rank Stock Value
1
DOCS icon
Doximity
DOCS
+$4.86M

Top Sells

Rank Stock Value
1
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
+$1.42M

Sector Composition

Rank Sector Weight
1 Consumer Staples 65.66%
2 Financials 18.16%
3 Technology 11.52%
4 Real Estate 2.48%
5 Healthcare 2.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KDP icon
1
Keurig Dr Pepper
KDP
$42.3B
$108M 58.8%
3,001,248
– –
DNB
2
DELISTED
Dun & Bradstreet
DNB
$33.2M 18.16%
2,679,211
– –
DNUT icon
3
Krispy Kreme
DNUT
$569M
$12.5M 6.86%
1,087,353
– –
NABL icon
4
N-able
NABL
$695M
$11.4M 6.26%
1,239,867
– –
SWI
5
DELISTED
SolarWinds Corporation Common Stock
SWI
$9.61M 5.26%
1,239,867
– –
COMP icon
6
Compass
COMP
$10.2B
$4.53M 2.48%
1,951,155
– –
DOCS icon
7
Doximity
DOCS
$4.74B
$4.01M 2.19%
+132,727
New +$4.86M
NGM
8
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
– –
-110,428
Closed -$1.42M

Similar funds

RA
RoundAngle Advisors Red Bank, New Jersey $134M AUM 27.87% 1-Year Est. Return
SWM
Shepherd Wealth Management Cincinnati, Ohio $134M AUM 45.23% 1-Year Est. Return
SA
Spear Advisors East Hampton, New York $134M AUM
SA
Seneschal Advisors Tacoma, Washington $135M AUM 13.18% 1-Year Est. Return
GEH
General Equity Holdings Brooklyn, New York $135M AUM 32.96% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
MMCM
Murphy & Mullick Capital Management Smithtown, New York $135M AUM 29.14% 1-Year Est. Return
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return

Lexington Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Lexington Partners held 8 positions worth $183M, down 5.6% from $194M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Lexington Partners's Q3 2022 filing shows 1 new and 1 closed positions. Its largest new stake was Doximity: 132,727 shares worth $4.01M. The largest sale was NGM Biopharmaceuticals, Inc. Common Stock, an estimated $1.42M.

By sector, the portfolio is most concentrated in Consumer Staples at 66% of assets, up from 63% a quarter earlier, followed by Financials and Technology.

  • Lexington Partners's largest Q3 2022 buy was Doximity: 132,727 shares worth $4.01M.
  • Lexington Partners fully exited NGM Biopharmaceuticals, Inc. Common Stock in Q3 2022, selling an estimated $1.42M.
  • Lexington Partners's ten largest holdings make up 100% of its $183M portfolio in Q3 2022.
  • Lexington Partners opened 1 new position and closed 1 in Q3 2022.
  • Lexington Partners's portfolio value fell 5.6% quarter-over-quarter to $183M.

Based on Lexington Partners's 13F filing for Q3 2022, filed 14 Nov 2022.